Eligibility: Any woman at least 18 years old who is receiving care at the University of Iowa Women’s Health Care clinics or inpatient facilities and is also able to provide informed consent. Women cannot participate if they are HIV+ or Hepatitis C+.
About: The purpose of this research study is to develop a bank of samples of from girls and women who are seeking care at the Women’s Health center. These samples include blood, urine, and tissue specimens obtained in any procedure in the clinic. We will collect these samples as part of your routine care, such as during a blood draw. Researchers will utilize DNA, RNA, and protein from samples to study women’s health issues. Some of the diseases studied may include but are not limited to, gynecological and reproductive issues, cancer, and pregnancy.
UI study seeks participants with pelvic pain
Women age 18 and older with pelvic pain or discomfort associated with frequent urination or urgency to urinate, as well as adult women with pelvic pain from interstitial cystitis are invited to participate in a University of Iowa research study on the conditions.
The study aims to help reveal what causes the conditions with the goal of improving diagnosis and treatment. However, the study itself does not include treatment.
Both interstitial cystitis and painful bladder syndrome can cause pain or discomfort in the pelvis or lower abdomen and the need to urinate more often than normal.
The study involves one visit to UI Hospitals and Clinics. This visit will last three to four hours. The visit includes blood, urine and DNA tests, and a pelvic exam. Participants also will take a pain test.
Women who are pregnant are not eligible to participate in the study.
The study tests are provided at no cost. Compensation is available. The study is funded by the National Institutes of Health.
For more information, contact Mary Eno, study coordinator, at 866-309-0834 or email@example.com.
Mary Eno, RN, Research Associate
firstname.lastname@example.org or 866-309-0834 or 319-384-9265
Participants in this research study have bladder cancer (also known as urothelial cancer) that is confined to the bladder but invades into the deep portion of the bladder and requires bladder removal with removal of the lymph nodes in the pelvis. The purpose of this research study is to compare the effects, good and/or bad, of performing a standard lymph node removal versus an extended lymph node removal at the time that participants are having surgery to remove their bladders. The extended lymph node surgery removes additional lymph nodes that are farther away from the bladder than those removed during standard lymph node surgery. Lymph nodes are present throughout the body and function normally to fight infection. They may also trap cancer cells that spread from a tumor. This is also referred to as metastasis. It is important remove the lymph nodes near the bladder to determine if they contain bladder cancer cells that have spread beyond the bladder. While extended lymph node removal is done commonly at some centers it is still considered experimental since investigators do not know if the additional surgery improves outcome. Approximately 6 people will take part in this study conducted by investigators at the University of Iowa.
Clarine Halvorsen, 319-356-3944
Participants in this research study have prostate cancer that has spread and they are either beginning hormone therapy for the first time or have been on hormone therapy for less than 30 days.
The purpose of this research study is to find out what effects (good and/or bad) there are to adding the new investigational drug TAK-700 (also called orteronel) to standard hormone therapy which is used to treat prostate cancer as compared to the standard of hormone therapy alone. “Investigational” means that the drug has not been approved by the U.S. Food and Drug Administration (FDA) for the treatment of prostate cancer. The combination of TAK-700 and standard hormone therapy is considered experimental (investigational).
Approximately 20 people will take part in this study conducted by investigators at the University of Iowa. Approximately 1,636 people will take part in this study nationwide.
Adolescents between the ages of 13-16 with a first degree relative (full-sibling or biological parent) diagnosed with schizophrenia, schizoaffective or schizophreniform disorder are invited to participate in a research study investigating brain connectivity and development in teens conducted at the UI Department of Psychiatry. The study includes 2 MRI scans and requires 3 visits to the University of Iowa Hospitals and Clinics and 4 follow-up phone calls over a 3-year period. Compensation is available. For more information, call Julie at (319) 384-6521 or email@example.com or toll free 1-866-890-5972.
Copyright © 2013 The University of Iowa. All Rights Reserved.